Delivery Order SPE2DB24D2106-SPE2DB25FAWGA
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,745.97 by the Defense Logistics Agency (DLA) on September 19, 2025. The delivery order, which carries no set-aside designation, covers the supply of Yuvafem 10 microgram vaginal inserts (18 units) with performance at the company's facility in Conshohocken, Pennsylvania, and an ultimate completion date of September 22,...
- The Defense Logistics Agency awarded a delivery order valued at $2,478.02 to DMS Pharmaceutical Group Inc. for Yuvafem 10 mcg vaginal inserts (18-count units) on October 29, 2025, with performance completion scheduled for October 30, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement....
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of Yuvafem 10 MCG vaginal inserts, with a total ceiling value of $1,611.60 and an ultimate completion date of July 9, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois, that specializes in providing a range of pharmaceutical products to federal agencies,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,659.73 contract is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S, a specialized pharmaceutical product. The contract has an ultimate completion date of July 17, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,916.25 firm fixed-price award is for the delivery of YUVAFEM 10 MCG vaginal inserts. The award is under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC vehicle, under the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,906.93, is for the delivery of 4564788297 ! YUVAFEM 10 MCG VAGINAL INSERT 18S, a specialized pharmaceutical product, with a completion date of June 4, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,813.40 delivery order is for the provision of YUVAFEM 10 MCG vaginal inserts. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to issue firm...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,621.42 for 1,000 units of Estrogens 0.625mg by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract is a firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of August 26, 2025. This delivery order falls under DMS Pharmaceutical Group's larger single-award...
- The U.S. Defense Logistics Agency has awarded a delivery order valued at $25,689.47 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Etonogestrel 68mg contraceptive implants. This firm fixed-price delivery order, awarded on September 29, 2025, with an ultimate completion date of the same date, represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $32,816.60 by the Defense Logistics Agency's Medical Supply Chain division on September 15, 2025, with an ultimate completion date of September 16, 2025. This delivery order was issued without a set-aside designation and represents a single purchase order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAWGADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,125.54 to DMS Pharmaceutical Group Inc. for Yuvafem 10 microgram vaginal inserts (18-unit package), with performance in Conshohocken, Pennsylvania and completion by September 5, 2025. This firm fixed-price delivery order was awarded without a set-aside designation on September 4, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as the prime contractor and will fulfill this pharmaceutical supply requirement for federal healthcare systems. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million and valid through November 2026. The IDC enables DLA to procure a comprehensive range of pharmaceutical products, including prescription medications, biologics, and medical consumables to support military health facilities nationwide. DMS Pharmaceutical Group has established itself as a key supplier within the federal pharmaceutical supply chain through consistent performance on DLA contracts covering diverse medical products ranging from contraceptives to oncology treatments and specialty medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 9/4/25 |